Maria Dobek, Vice President, Accounting at Janux Therapeutics, Inc. (JANX), sold 2,038 shares at $14.17 ($29K) on 2026-05-11, disclosed to the SEC on 2026-05-13.
Open-market sale of $29k JANX by Vice President, Accounting. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.